Sign up to save your podcasts
Or
Share Canadian Expert discussion on the treatment and management considerations for MIBC treatment regimens
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Canadian Expert discussion on the treatment and management considerations for MIBC treatment regimens
Episode Notes
Podcast Host Disclosures:
Dr. Black has received honoraria from AbbVie, Astellas Pharma, AstraZeneca, Bayer, Biosyent, Bristol- Myers Squibb, EMD-Serono, Ferring, Janssen Oncology, Merck, Nanology, Nonagen, Pfizer, Prokarium, Protara, QED, Roche Canada, Sanofi Canada, STIMIT, Urogen Pharma and Verity
Dr. Lalani has received honoraria from AbbVie, Astellas, AstraZeneca, Bayer, BMS, Eisai, EMD Serono, Ipsen, Janssen, McKesson, Merck, Novartis, Pfizer, Roche, TerSera. Funding for clinical trials directed to institutions from BMS (Inst), BioCanRx (Inst), Novartis (Inst), Roche (Inst), Ipsen (Inst), EMD Serrono (Inst).
Accreditation:
This podcast was accredited by the Canadian Urological Association in accordance with the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.
After completing the self-assessment questions at the link below, listeners are eligible to claim Section 3 self-assessment credits.
Obtain Section 3 Credits Here >
View all episodes
By Canadian Urological Association / L'Association des urologues du CanadaEpisode Notes
Podcast Host Disclosures:
Dr. Black has received honoraria from AbbVie, Astellas Pharma, AstraZeneca, Bayer, Biosyent, Bristol- Myers Squibb, EMD-Serono, Ferring, Janssen Oncology, Merck, Nanology, Nonagen, Pfizer, Prokarium, Protara, QED, Roche Canada, Sanofi Canada, STIMIT, Urogen Pharma and Verity
Dr. Lalani has received honoraria from AbbVie, Astellas, AstraZeneca, Bayer, BMS, Eisai, EMD Serono, Ipsen, Janssen, McKesson, Merck, Novartis, Pfizer, Roche, TerSera. Funding for clinical trials directed to institutions from BMS (Inst), BioCanRx (Inst), Novartis (Inst), Roche (Inst), Ipsen (Inst), EMD Serrono (Inst).
Accreditation:
This podcast was accredited by the Canadian Urological Association in accordance with the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.
After completing the self-assessment questions at the link below, listeners are eligible to claim Section 3 self-assessment credits.
Obtain Section 3 Credits Here >